US Stock MarketDetailed Quotes

UTMD Utah Medical Products

Watchlist

66.780
-0.280-0.42%

Close Jun 14 16:00 ET

66.780
0.0000.00%

Post 16:05 ET

235.63MMarket Cap14.84P/E (TTM)

Utah Medical Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-9.42%11.34M

-3.93%50.22M

-9.14%12.33M

-3.47%12.51M

-4.19%12.87M

1.60%12.52M

6.58%52.28M

5.11%13.57M

3.05%12.96M

6.54%13.43M

Operating revenue

-9.42%11.34M

-3.93%50.22M

-9.14%12.33M

-3.47%12.51M

-4.19%12.87M

1.60%12.52M

6.58%52.28M

5.11%13.57M

3.05%12.96M

6.54%13.43M

Cost of revenue

-2.20%4.57M

0.50%20.19M

-0.23%5.24M

7.91%5.15M

-2.84%5.13M

-2.36%4.68M

10.74%20.09M

9.29%5.25M

6.00%4.77M

9.50%5.28M

Gross profit

-13.73%6.77M

-6.70%30.04M

-14.76%7.1M

-10.10%7.36M

-5.05%7.74M

4.12%7.84M

4.14%32.2M

2.64%8.33M

1.40%8.19M

4.70%8.15M

Operating expense

-28.58%2.14M

6.89%13.26M

-3.16%3.15M

11.33%3.39M

7.11%3.31M

-0.53%3M

3.07%12.41M

9.19%3.26M

2.35%3.05M

2.45%3.09M

Selling and administrative expenses

8.39%1.37M

6.61%12.7M

-4.02%3.01M

10.88%3.25M

7.50%3.18M

-56.27%1.26M

3.49%11.91M

10.27%3.13M

2.98%2.93M

2.32%2.96M

-Selling and marketing expense

6.46%412K

11.81%1.69M

----

--387K

6.58%1.51M

----

-General and administrative expense

9.25%957K

5.86%11.02M

----

--876K

3.06%10.41M

----

Research and development costs

84.72%266K

13.59%560K

18.70%146K

23.21%138K

-1.48%133K

17.07%144K

-6.27%493K

-12.77%123K

-11.81%112K

5.47%135K

Depreciation amortization depletion

-68.26%504K

----

--1.59M

----

-Depreciation and amortization

-68.26%504K

----

--1.59M

----

Operating profit

-4.56%4.63M

-15.22%16.78M

-22.21%3.94M

-22.80%3.97M

-12.50%4.43M

7.21%4.85M

4.82%19.79M

-1.17%5.07M

0.84%5.14M

6.13%5.06M

Net non-operating interest income expense

Other net income (expense)

-36.53%172K

281.13%3.31M

105.95%1.07M

310.10%812K

426.06%747K

3,287.50%271K

380.11%869K

921.57%521K

235.59%198K

136.67%142K

Gain on sale of security

----

359.30%3.04M

----

298.19%661K

----

Special income (charges)

-81.66%-743K

----

---409K

----

-Less:Other special charges

81.66%743K

----

--409K

----

Other non- operating income (expenses)

34.56%915K

32.69%276K

-1,302.14%-1.96M

310.10%812K

426.06%747K

8,400.00%680K

1,286.67%208K

-21.74%-140K

235.59%198K

136.67%142K

Income before tax

-6.27%4.8M

-2.76%20.09M

-10.27%5.02M

-10.45%4.78M

-0.52%5.17M

13.00%5.12M

8.38%20.66M

7.91%5.59M

3.53%5.34M

7.75%5.2M

Income tax

-6.96%842K

-17.49%3.45M

-29.44%731K

-20.11%846K

-11.31%972K

-9.14%905K

-2.04%4.19M

-1.24%1.04M

11.36%1.06M

-21.66%1.1M

Net income

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

1.76%4.28M

19.76%4.1M

Net income continuous Operations

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

1.76%4.28M

19.76%4.1M

Minority interest income

Net income attributable to the parent company

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

1.76%4.28M

19.76%4.1M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

1.76%4.28M

19.76%4.1M

Basic earnings per share

-6.03%1.09

1.10%4.58

-5.94%1.181

-8.47%1.08

2.65%1.16

19.59%1.16

11.85%4.53

11.08%1.2555

2.61%1.18

20.21%1.13

Diluted earnings per share

-6.03%1.09

1.11%4.57

-5.83%1.18

-8.47%1.08

2.68%1.15

20.83%1.16

11.88%4.52

11.18%1.253

2.61%1.18

19.15%1.12

Dividend per share

1.69%0.3

1.72%1.185

1.69%0.3

1.72%0.295

36.26%1.165

0.295

1.75%0.29

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	-9.42%11.34M	-3.93%50.22M	-9.14%12.33M	-3.47%12.51M	-4.19%12.87M	1.60%12.52M	6.58%52.28M	5.11%13.57M	3.05%12.96M	6.54%13.43M
Operating revenue	-9.42%11.34M	-3.93%50.22M	-9.14%12.33M	-3.47%12.51M	-4.19%12.87M	1.60%12.52M	6.58%52.28M	5.11%13.57M	3.05%12.96M	6.54%13.43M
Cost of revenue	-2.20%4.57M	0.50%20.19M	-0.23%5.24M	7.91%5.15M	-2.84%5.13M	-2.36%4.68M	10.74%20.09M	9.29%5.25M	6.00%4.77M	9.50%5.28M
Gross profit	-13.73%6.77M	-6.70%30.04M	-14.76%7.1M	-10.10%7.36M	-5.05%7.74M	4.12%7.84M	4.14%32.2M	2.64%8.33M	1.40%8.19M	4.70%8.15M
Operating expense	-28.58%2.14M	6.89%13.26M	-3.16%3.15M	11.33%3.39M	7.11%3.31M	-0.53%3M	3.07%12.41M	9.19%3.26M	2.35%3.05M	2.45%3.09M
Selling and administrative expenses	8.39%1.37M	6.61%12.7M	-4.02%3.01M	10.88%3.25M	7.50%3.18M	-56.27%1.26M	3.49%11.91M	10.27%3.13M	2.98%2.93M	2.32%2.96M
-Selling and marketing expense	6.46%412K	11.81%1.69M	----	----	----	--387K	6.58%1.51M	----	----	----
-General and administrative expense	9.25%957K	5.86%11.02M	----	----	----	--876K	3.06%10.41M	----	----	----
Research and development costs	84.72%266K	13.59%560K	18.70%146K	23.21%138K	-1.48%133K	17.07%144K	-6.27%493K	-12.77%123K	-11.81%112K	5.47%135K
Depreciation amortization depletion	-68.26%504K	----	----	----	----	--1.59M	----	----	----	----
-Depreciation and amortization	-68.26%504K	----	----	----	----	--1.59M	----	----	----	----
Operating profit	-4.56%4.63M	-15.22%16.78M	-22.21%3.94M	-22.80%3.97M	-12.50%4.43M	7.21%4.85M	4.82%19.79M	-1.17%5.07M	0.84%5.14M	6.13%5.06M
Net non-operating interest income expense
Other net income (expense)	-36.53%172K	281.13%3.31M	105.95%1.07M	310.10%812K	426.06%747K	3,287.50%271K	380.11%869K	921.57%521K	235.59%198K	136.67%142K
Gain on sale of security	----	359.30%3.04M	----	----	----	----	298.19%661K	----	----	----
Special income (charges)	-81.66%-743K	----	----	----	----	---409K	----	----	----	----
-Less:Other special charges	81.66%743K	----	----	----	----	--409K	----	----	----	----
Other non- operating income (expenses)	34.56%915K	32.69%276K	-1,302.14%-1.96M	310.10%812K	426.06%747K	8,400.00%680K	1,286.67%208K	-21.74%-140K	235.59%198K	136.67%142K
Income before tax	-6.27%4.8M	-2.76%20.09M	-10.27%5.02M	-10.45%4.78M	-0.52%5.17M	13.00%5.12M	8.38%20.66M	7.91%5.59M	3.53%5.34M	7.75%5.2M
Income tax	-6.96%842K	-17.49%3.45M	-29.44%731K	-20.11%846K	-11.31%972K	-9.14%905K	-2.04%4.19M	-1.24%1.04M	11.36%1.06M	-21.66%1.1M
Net income	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M	1.76%4.28M	19.76%4.1M
Net income continuous Operations	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M	1.76%4.28M	19.76%4.1M
Minority interest income
Net income attributable to the parent company	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M	1.76%4.28M	19.76%4.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M	1.76%4.28M	19.76%4.1M
Basic earnings per share	-6.03%1.09	1.10%4.58	-5.94%1.181	-8.47%1.08	2.65%1.16	19.59%1.16	11.85%4.53	11.08%1.2555	2.61%1.18	20.21%1.13
Diluted earnings per share	-6.03%1.09	1.11%4.57	-5.83%1.18	-8.47%1.08	2.68%1.15	20.83%1.16	11.88%4.52	11.18%1.253	2.61%1.18	19.15%1.12
Dividend per share	1.69%0.3	1.72%1.185	1.69%0.3	1.72%0.295	1.72%0.295	1.72%0.295	36.26%1.165	0.295	1.75%0.29	1.75%0.29
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall